Search Results for abdominal aortic aneurysm
Patient-facing literature from SVS found to exceed recommended reading level

A readability analysis of 15 publicly available patient education materials from the SVS found that all but three exceeded the 8th-grade reading level, the threshold at which the average adult in the U.S. reads. Additionally, all 15 breached the 6th-grade…
Closer to the goal: Shoring up data behind breakthrough imaging technology that plots a radiation-free future in new RCT

UMass chief peers down the lens of an if-not radiation-free complex aortic procedural future, then one in which the methods of today will look positively quaint. “I say this a lot,” says Andres Schanzer, MD, “but I think there is…
Shape Memory Medical announces midway milestone in AAA-SHAPE randomised controlled pivotal trial

Shape Memory Medical has reached 50 per cent enrolment in its ongoing AAA-SHAPE pivotal trial, the company announced last week. AAA-SHAPE is a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the Impede-FX RapidFill device to improve…
Randomized trial finds inferior mesenteric artery embolization ‘may not be effective’ in EVAR

Results from a multicenter randomized controlled trial (RCT) indicate that pre-emptive inferior mesenteric artery (IMA) embolisation during endovascular aneurysm repair (EVAR) does not significantly reduce aneurysm sac volume or rates of type II endoleak. The CLARIFY IMA study—which the authors…
Medtronic’s Endurant receives FDA labelling approval to remove rAAA treatment warning

Medtronic recently announced it has received Food and Drug Administration (FDA) labelling approval for the Endurant stent graft system, by adding ruptured abdominal aortic aneurysm (rAAA) clinical evidence and removing the rAAA treatment warning. A press release notes that this…
Nurea receives US FDA clearance for AI-powered PRAEVAorta 2 software

Nurea’s PRAEVAorta 2 artificial intelligence (AI)-powered software has received US Food and Drug Administration (FDA) 510(k) clearance, a company press release reveals. According to Nurea, PRAEVAorta 2 provides vascular physicians with advanced automated measurement tools for aortic diameters on contrasted…
MVSS 2025: Gore iliac branch device ‘equally effective’ in both IDE and registry studies

Researchers have reported comparable five-year outcomes of the Gore Excluder iliac branch endoprosthesis (IBE; Gore) in both the investigational device exemption (IDE) and GREAT registry studies of the device. Meghan Barber, MD, a vascular surgery fellow at the University of…
Shifting demographics, improved visibility and strides made on Medicare reimbursements

This is the latest monthly update on a few of the critical issues facing the SVS. Changing SVS leadership demographics Over the last several years, the SVS Leadership and Appointments Committee made a determined effort to be more inclusive of…
Final patient treated in Cook’s Zenith Fenestrated+ endovascular graft clinical study

Cook Medical has enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular graft (ZFEN+), signifying completion of patient recruitment in the pivotal study. The investigational ZFEN+ clinical study is being conducted under an Investigational Device Exemption…
AI: Where it lands today and how it might impact the vascular future

The speed with which artificial intelligence (AI) is beginning to envelope aspects of the human experience strikes many as jarring. Its entrance into the world of vascular surgery, too, has picked up a pace in recent years, with models and…

